摘要
目的评估芪丹通脉片(QDTMT)治疗冠心病心绞痛的有效性和安全性.方法将208例冠心病心绞痛患者,随机分为试验组(n=105)和对照组(n=103).分别给试验组和对照组口服芪丹通脉片(QDTMT)4片,养心氏片(YXST)2片,3次/d,28d.结果试验组患者心绞痛总有效率78.64%,中医征候总有效率91.26%,心电图总有效率45.63%;对照组分别为71.57%,86.40%,33.98%;两组治疗过程,未见不良反应.结论芪丹通脉片对冠心病心绞痛有较好的治疗效果,而且安全可靠.
AIM： To evaluate the efficacy and safety of Qidantongmai tablet （QDTMT） in the treatment of angina pectoris caused by coronary heart disease. METHODS： A total of 208 patients were randomly assigned to QDTMT group （ n = 105 ） and Yangxinshi tablet （YXST） group（ n = 103 ）. QDTMT 4 pills and YXST 2 pills had been taken 3 times a day for 28 d to different groups with angina pectoris caused by coronary heart disease. RESUILTS： In QDTMT group, the total effective rate for angina pectoris was 78.64% and for traditional Chinese medicine symptoms was 91.26%, and the total improvement rate of electrocardiogram was 45.63%. In YXST group, the total effective rate for angina pectoris was 71.57% and for traditional Chinese medicine symptoms was 86.40%, and the total improvement rate of electrocardiogram was 33.98%. CONCLUSION： QDTMT was not only effective in the treatment of angina pectoris caused by coronary heart disease, but also safe to patients.
出处
《第四军医大学学报》
CAS
北大核心
2006年第16期1505-1508,共4页
Journal of the Fourth Military Medical University
基金
陕西省攻关课题(2001K12-G7)
关键词
芪丹通脉片
冠状动脉疾病
心绞痛
Qidantongmai tablet
coronary disease
angina pectoris
